OPTFSNA
IOVA icon

Old Point Trust & Financial Services N A’s Iovance Biotherapeutics IOVA Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250
Closed -$3.71K – 435
2024
Q1 		$3.71K Buy
+250
New +$2.91K ﹤0.01% 375

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Old Point Trust & Financial Services N A's IOVA Position: Q2 2024 in Review

Old Point Trust & Financial Services N A sold out of Iovance Biotherapeutics (IOVA) in Q2 2024, closing a stake of 250 shares — an estimated $3.71K sold.

Old Point Trust & Financial Services N A first reported a position in IOVA in Q1 2024 and held it in 1 quarter. The position peaked at $3.71K in Q1 2024. 295 funds tracked by Wall St. Rank hold IOVA as of Q2 2024.

  • Old Point Trust & Financial Services N A reported no remaining Iovance Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Old Point Trust & Financial Services N A sold 250 Iovance Biotherapeutics shares in Q2 2024, an estimated $3.71K.
  • Old Point Trust & Financial Services N A first reported a position in Iovance Biotherapeutics in Q1 2024 and held it in 1 quarter.
  • Old Point Trust & Financial Services N A's Iovance Biotherapeutics position peaked at $3.71K in Q1 2024.
  • 295 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2024.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2024, filed 13 Aug 2024.